Institutional Review Board, Hospital for Special Surgery
May 16, 2021
The safety of study participants is our top priority. The trial is approved and periodically reviewed by an Institutional Review Board (IRB), which includes doctors, administrators, ethicists, and members of the general public. The safety of clinical trials is reviewed by the U.S. Food and Drug Administration.
Before enrolling in a clinical trial, the investigator will explain the purpose of the trial, its expected benefits, any possible risks or side effects, and what your role will be. This is the time to ask questions! If you want to join the trial, you must sign the informed consent documents. You can leave a clinical trial at any time without penalty.
For further information, see Understanding Clinical Trials.
Daphne I. Ling PhD, MPH
Ellen Casey, MD
Theresa Chiaia, PT, DPT
Polly de Mille RN, MA, RCEP, CSCS, USAT
Jo A Hannafin, MD, PhD
Teena Shetty, MD
Heidi Prather, DO
Erin E. Manning, MD
This research study is designed to address the gender gap that is found in the health literature.
The first phase is an anonymous online survey that is open to retired/former women’s soccer players who have played at the elite level (i.e., NCAA, Semi-Professional, Professional, or Senior National Team). The questions relate to 5 areas of health: physical, musculoskeletal, female athlete, neurocognitive, and mental. The survey is expected to take 10-20 minutes.
We hope that our initial findings will lay the foundation for future long-term research on the health of female athletes.
Participants need to be retired or former players who are 70 years of age or younger. For the purpose of this study, we are defining elite level as any of the following:
In addition, participants need to be physically located in the US due to data privacy regulations.
Daphne I. Ling, PhD, MPH
Epidemiologist, HSS Sports Medicine Institute
Assistant Professor, Weill Cornell Medicine